Crystal Structure of 2-(Pyridin-4-yl)-5-(Undecylthio)-1,3,4-Oxadiazole

被引:0
|
作者
Z.-H. Shen
Q. Wang
Z.-H. Sun
H.-K. Wu
C.-X. Tan
J.-Q. Weng
X.-H. Liu
机构
[1] Zhejiang University of Technology,College of Chemical Engineering
来源
关键词
heterocycle; synthesis; crystal structure;
D O I
暂无
中图分类号
学科分类号
摘要
The title compound 2-(pyridin-4-yl)-5-(undecylthio)-1,3,4-oxadiazole (C18H27ON3S) is synthesized, and its structure is confirmed by 1H NMR, MS, elemental analyses and X-ray diffraction. It crystallizes in the monoclinic system, space group P2(1)/c with a = 24.453(17) Å, b = 10.604(7) Å, c = 7.095(5) Å, β = 91.60(2)°, V = 1839(2) Å3, Z = 4, and R = 0.086 for 2295 observed reflections with I > 2σ(I). The preliminary biological test shows that the title compound has good activity against Pythium ultimum with inhibitory to be 77.78%.
引用
收藏
页码:1236 / 1240
页数:4
相关论文
共 50 条
  • [41] Synthesis, crystal structure and spectroscopic properties of copper(II) complexes derived from 2-methylamino-5-pyridin-2-yl-1,3,4-oxadiazole
    Gómez-Saiz, P
    García-Tojal, J
    Maestro, MA
    Mahía, J
    Arnáiz, FJ
    Rojo, T
    POLYHEDRON, 2002, 21 (22) : 2257 - 2263
  • [42] Synthesis, X-ray crystal structure and optical properties of novel 5-(3-aryl-1H-pyrazol-5-yl)-2-(6-methoxy-3-methylbenzofuran-2-yl)-1,3,4-oxadiazole
    Jiang, Zhen-Ju
    Liu, Jin-Ting
    Lv, Hong-Shui
    Zhao, Bao-Xiang
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2012, 86 : 181 - 186
  • [43] Crystal structure of 2-(5-(pyridin-3-yl)-4-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine, C17H12N6
    Sun, Hongtao
    Wu, Hao
    Zhang, Lili
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (05): : 1161 - 1162
  • [44] Synthesis, Crystal Structure and Biological Activity of 2-(Anthracen-9-yl)-5-p-tolyl-1,3,4-oxadiazole
    Li Xin-Wei
    He Dao-Hang
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2012, 31 (03) : 367 - 372
  • [45] The crystal structure of 2-(4-fluorophenyl)-1,3,4-oxadiazole, C8H5FN20
    Zhou, Zhixu
    Long, Dan
    Wu, Qing-Mei
    Yu, De-Hou
    Lu, Hong-Guang
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2019, 234 (01): : 153 - 154
  • [46] Synthesis,Crystal Structure and Biological Activity of 2-(Anthracen-9-yl)-5-p-tolyl-1,3,4-oxadiazole
    李新伟
    何道航
    结构化学, 2012, 31 (03) : 367 - 372
  • [47] Vibrational analysis of 2-[4-( N -dodecanoylamino)phenyl]-5-(4-nitrophenyl)-1,3,4-oxadiazole
    B. Jordanov
    D. Tsankov
    K. Hinrichs
    R. Dietel
    E. H. Korte
    Analytical and Bioanalytical Chemistry, 2003, 375 : 1246 - 1249
  • [48] Crystal structure of 2-(1-benzyl-3-phenyl-1H-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S
    Huang, Xu-Wen
    You, Jin-Zong
    Ni, Wan-Min
    Zhang, Yi-Ping
    Feng, Qi
    Xu, Wen-Chang
    Tong, Sheng-Yue
    Li, Tang-Qi
    Qi, De-Qiang
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2017, 232 (03): : 357 - 358
  • [49] Synthesis and Antifungal Screening of 2-(2-Aryl-4-methyl-thiazol-5-yl)-5-((2-aryl/benzylthiazol-4-yl)methyl)-1,3,4-oxadiazole Derivatives
    Mhaske, Pravin C.
    Shelke, Shivaji H.
    Gadge, Kisan
    Shinde, Abhijit
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2016, 53 (01) : 129 - 134
  • [50] The synthesis, characterization and optical properties of novel 5-(3-aryl-1H-pyrazol-5-yl)-2-(3-butyl-1-chloroimidazo[1,5-a]pyridin-7-yl)-1,3,4-oxadiazole
    Ge, Yan Qing
    Jia, Jiong
    Wang, Teng
    Sun, Hong Wei
    Duan, Gui Yun
    Wang, Jian Wu
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2014, 123 : 336 - 341